Profile
Jing Zhen Deng served as the Chief Executive Officer of Jiangsu Suxantang Pharmaceutical Co. Ltd.
from 2018 to 2019.
Prior to that, he was the Chief Executive Officer of RCT Pharmaceuticals, Inc. and Director of Research & Development at Pinnacle Pharmaceuticals, Inc. and Drumetix Laboratories.
Deng also served as the Chief Operation & Scientific Officer of China Sxt Pharmaceuticals, Inc. from 2017 to 2021.
Deng received his undergraduate degree from Jiangxi University of Traditional Chinese Medicine in 1982 and his graduate and doctorate degrees from China Pharmaceutical University in 1989 and 1992, respectively.
Former positions of Jing Zhen Deng
| Companies | Position | End |
|---|---|---|
| CHINA SXT PHARMACEUTICALS, INC. | Chief Operating Officer | 2021-12-14 |
| Jiangsu Suxantang Pharmaceutical Co. Ltd. | Chief Executive Officer | 2019-12-30 |
| RCT Pharmaceuticals, Inc. | Chief Executive Officer | - |
| Drumetix Laboratories | Chief Tech/Sci/R&D Officer | - |
| Pinnacle Pharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | - |
Training of Jing Zhen Deng
| Jiangxi University of Traditional Chinese Medicine | Undergraduate Degree |
| China Pharmaceutical University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHINA SXT PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
| Jiangsu Suxantang Pharmaceutical Co. Ltd. | |
| Pinnacle Pharmaceuticals, Inc. | |
| Drumetix Laboratories | |
| RCT Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Jing Zhen Deng
